Discovery Legacy

Legacy Biospecimens. Curated for Discovery.

Gain exclusive access to a scientifically curated collection of quality-tested and highly characterized legacy biospecimens (DTCs, PBMCs, plasma, frozen tissue, BMMCs, leukopaks, and bone marrow) to uncover new retrospective insights, at a pace and price that accelerates innovation

About Discovery Legacy

With 200,000+ samples available—and 30–40% including patient follow-up data—this curated collection of legacy biospecimens unlock limitless opportunities for researchers.

This collection is continuously updated as new biospecimens age into eligibility, providing a dynamic inventory that grows over time to accelerate innovation in genomics, biomarker discovery, immunology, and beyond. 

Why Choose Discovery Legacy?

Choosing Discovery Legacy means gaining access to samples that are uniquely positioned to answer today’s most pressing research questions: 

  • Budget-Friendly: Save 40% on all biospecimens in our legacy inventory without compromising on quality.  Additionally, save 60% on AllCells® cryopreserved leukopaks, mobilized leukopaks, and bone marrow from non-recallable donors
  • Longitudinal Insights: track biological changes over time 
  • Retrospective Studies: explore new research questions using archived samples 
  • Stability Testing: evaluate biomarker integrity and assay reproducibility over time 
  • Baseline References: establish baseline controls for PBMCs for immune-response archiving, frozen tissues for genomic stability checks, and more 

Frequently Asked Questions

Exclusive program providing access to a curated collection of legacy biospecimens available at budget-friendly pricing to support retrospective and longitudinal research. 

Enrollment is free. Simply fill out the contact form, and you will be notified of your application status within 2 business days. 

To remain in the program, participating customers must make at least one purchase every 3 months and maintain no outstanding invoices. 

The program includes all inventoried biospecimen products aged 3 years or older, excluding tumoroids, archival tissues, and certain FFPE with rare indications and/or mutations

Yes. The Discovery Legacy inventory is continuously updated as new biospecimens age into eligibility. This ensures the collection remains dynamic, providing members with ongoing access to a pool of legacy samples. 

Enroll Today

Quick Links

Technologies

Development and Clinical
Trial Solutions

Privacy Settings